Electroporation designates the use of short high-voltage pulses to overcome the barrier of the cell membrane. By applying an external electric field, which just surpasses the capacitance of the cell membrane, transient and reversible breakdown of the membrane can be induced. This transient, permeabilized state can be used to load cells with a variety of different molecules, either through simple diffusion in the case of small molecules, or through electrophoretically driven processes allowing passage through the destabilized membrane -as is the case for DNA transfer. Initially developed for gene transfer, electroporation is now in use for delivery of a large variety of molecules: From ions to drugs, dyes, tracers, antibodies, and oligonucleotides to RNA and DNA. Electroporation has proven useful both in vitro, in vivo and in patients, where drug delivery to malignant tumours has been performed. Whereas initial electroporation procedures caused considerable cell damage, developments over the past decades have led to sophistication of equipment and optimization of protocols. The electroporation procedures used in many laboratories could be optimized with limited effort. This review (i) outlines the theory of electroporation, (ii) discusses factors of importance for optimization of electroporation protocols for mammalian cells, (iii) addresses particular concerns when using electroporation in vivo, e.g. effects on blood flow and considerations regarding choice of electrodes, (iv) describes DNA electrotransfer with emphasis on use in the in vivo setting, and (v) sums up data on safety and efficacy of electroporation used to enhance delivery of chemotherapy to tumours in cancer patients.
cells in the in vitro setting were reported (e.g. Melvik et al. 1986 ; from the early 1990s, studies on in vivo electroporation also came forth (e.g. Okino & Mohri 1987 , Salford et al. 1993 , Heller et al. 1995 . The first clinical study on the use of electroporation to increase uptake in tumours of a chemotherapeutic agent was reported by Belehradek et al. (1993) , and since then several studies have been published on this aspect (e.g. Heller et al. 1998 , Panje et al. 1998 , Gehl & Geertsen 2000 , Sersa et al. 2000a .
Over the last two decades, electroporation equipment has been refined. Notably, square wave pulse generators have been constructed. These generators modify the exponential pulse to a square pulse, where pulse amplitude and pulse length can be independently controlled, an important prerequisite for optimization. There are ongoing efforts to optimize delivery of molecules while preserving cell viability through various technical optimizations, resulting in new equipment now commercially available or under way.
Theory of electroporation

The process of electroporation
The transmembrane potential induced in a cell by an external field is generally described by the equation:
where V m is the transmembrane potential, f a form factor describing the impact of the cell on the extracellular field distribution, E ext the applied electric field, r the cell radius and U the polar angle with respect to the external field. The value for the factor f is listed by many authors as 1.5; however, this factor is dependent on a number of different factors (see, e.g. Kotnik et al. 1997 Kotnik et al. , 1998 . Electroporation is achieved when the DV m superimposed on the resting transmembrane potential is larger than a threshold, DV s As the bilayer membrane is a common feature for eucaryotic cells, DV s is similar for various cell types. DV s is generally reported to be in the order of 1 V (Kinosita & Tsong 1977a) , although an experimental and theoretical study has later described it as being 200 mV (Teissie & Rols 1993) .
A very general consideration is that the smaller the cell radius, the larger the external field needed to achieve permeabilization (eqn 1). For this reason, the electric fields necessary to permeabilize mammalian cells are considerably lower than those needed to permeabilize, e.g. bacteria. It is also evident that, e.g. mitochondria or other intracellular organelles will not be permeabilized by E-fields of the size sufficient to permeabilize the cell membrane.
A new aspect of electroporation is, however, that by using extremely short pulses in the nanosecond range at very high voltages, cellular organelles can be electroporated without the cell membrane being permeabilized. This is possible when using pulses so short, that the charging time of the cell membrane is not reached (see Schoenbach et al. 2001) . Equipment for this type of electroporation is still in experimental set-up only.
The resting transmembrane potential is important not only for the threshold for permeabilization but also for the sequence of events. Permeabilization will initially happen at the pole of the cell facing the positive electrode, because owing to the negative interior of the cell this is where the capacitance of the membrane is first exceeded when an external field is applied (Fig. 1) . The second event is permeabilization of the pole of the cell facing the negative electrode (Fig. 1) . The extent of permeabilization (area of membrane which is permeabilized) on the pole facing the positive electrode can be controlled by pulse amplitude, i.e. the higher the pulse amplitude, the Figure 1 Top panel: Electroporation occurs when an applied external field exceeds the capacity of the cell membrane. It is proposed that water enters the cell membrane during the dielectric breakdown and that transient hydrophilic pores are formed (for reviews, see Weaver 1994 , Neumann et al. 1999 . The formation of permeable areas happens in the frame in less than a second whereas resealing happens over minutes. Bottom left: As the resting transmembrane potential is negative on the inside respective to the outside, the first part of the membrane that will be permeabilized is the pole facing the positive electrode. The area of the membrane permeabilized is larger the higher the pulse amplitude, whereas longer pulses will cause greater perturbation of the area permeabilized. See text for further details. Bottom right: The positive electrode should be imagined in the left of the picture and the negative electrode on the right. One 20-ms pulse of 1 kV cm )1 was delivered to a CHO cell suspended in medium containing propidium iodide. The image was recorded less than 40 ms after the pulses using a rapid ultra-low-light camera, as described by Gabriel & Teissie (1997) . This experiment was performed by B. Gabriel, who kindly permitted reproduction.
greater the area through which diffusion can take place (Gabriel & Teissie 1997) . The degree of permeabilization can be controlled by the pulse duration (and also pulse number), i.e. the longer the pulse the greater the perturbation of the membrane in a given area (Gabriel & Teissie 1997) . It has been shown that the area of the membrane being permeabilized is larger on the pole facing the positive electrode, but the degree of permeabilization is greater on the cell pole facing the negative electrode (Tekle et al. 1990) . Thus, larger molecules will be able to diffuse into the cell at the pole facing the negative electrode, but the area over which diffusion can take place is larger by the positive electrode (Tekle et al. 1990 ). For small molecules, diffusion alone is the cause of intracellular uptake, and uptake takes place regardless of charge (Neumann et al. 1998) . With increasing molecule size, uptake is affected but molecules up to the size of antibodies and dextrans have been loaded by electroporation (see, e.g. Glogauer & McCulloch 1992 , Verspohl et al. 1997 .
The uptake of DNA is not a result of diffusion, as evidenced by both in vitro studies (e.g. Golzio et al. 1998) and in vivo studies (e.g. Mir et al. 1999) . It has already been shown that electrophoretic forces are important for successful DNA transfection by electroporation (Sukharev et al. 1992) . Later, it has been shown that, in a study using DNA in suspension under an artificial bilipid layer, when applying the electric field, the presence of DNA facilitates pore formation through direct interaction with the membrane (Spassova et al. 1994 ).
An electrophoretic effect of the field causes the polyanion DNA to travel towards the positive electrode, and fluorescensce studies have shown that DNA enters the cell through the pole facing the negative electrode, where the membrane is more destabilized and where the field will drive the DNA towards the centre of the cell (Golzio et al. 2002) . Once the DNA has entered the cell, there is active participation by the cell in the further processing of the DNA, as shown by ATP dependence of this step (Rols et al. 1998a) .
In summary, because of the nature of electroporation, virtually any molecule can be introduced into cells. Consequently, electroporation has been used to introduce ions, dyes , Dinchuk et al. 1992 , Gehl et al. 1998 , radiotracers (Engstrom et al. 1999 , drugs (Belehradek et al. 1994 , Sersa et al. 1995 , Gehl et al. 1998 , Jaroszeski et al. 2000a , oligonucleotides (Spiller et al. 1998) , in addition to RNA (Teruel et al. 1999 , Saeboe-Larssen et al. 2002 and DNA (Neumann et al. 1982 , Heller et al. 1996 , Rols et al. 1998b , Mir et al. 1999 .
Membrane resealing
Whereas pore formation happens in the microsecond time frame, membrane resealing happens over a range of minutes.
Membrane resealing was first described in erythrocyte ghosts by Kinosita & Tsong (1977a) . Since then, several authors have looked into membrane resealing in vitro (e.g. Rols & Teissie 1990 , Lee et al. 1992 . A very nice theoretical study based on empirical data has been published by Saulis (1997) .
In vitro data have shown that resealing happens over the minute range (Rols & Teissie 1990) , with variations depending on electrical parameters used and on temperature. It has also been shown that intact function of the cytoskeleton is of importance for pore closure .
In vivo data describing membrane resealing in mouse skeletal muscle tissue (Gehl et al. 2002) found the 63% resealing time (s) to be approximately 9 min, which is similar to what was found in a previous ex vivo study of rat skeletal muscle (Bier et al. 1999) .
A subject for discussion is the issue of irreversible permeabilization. It is clear that irreversible permeabilization ensues with the use of extremely strong pulses. But whether there are possibilities for slow recovery of cells after extensive permeabilization and loss of intracellular components is unclear. There are indications that cell death from electroporation is more likely to occur in vitro than in vivo, most likely because of the fact that loss of intracellular molecules would be larger when there is abundant extracellular volume than when the extracellular space is comparatively small, as is the case in tissues .
Interestingly, it has been shown that the surfactant poloxamer 188 can increase the rate of resealing. It has been established that electroporation of muscle tissue plays an important role in the pathology of electric trauma (Lee et al. 1992) . Efforts to alleviate the sequels of electric trauma have led to the search for Ômembrane-sealing compoundsÕ, and the surfactant poloxamer 188 has a possible role in the management of electric trauma victims (Lee et al. 1992) .
Optimization of in vitro electroporation protocols
Whereas cell survival is generally not a problem when working with bacterial transfections, this is a concern for transfection of mammalian cells. An important improvement was the construction of square wave pulse generators, where pulse duration and amplitude can be controlled separately. Optimization of protocols has led to a situation where high cell viability can be combined with high percentages of cell permeabilization and/or gene transfection.
It is achievable to have over 90% of cells permeabilized with less than 5% cell death (e.g. Gehl et al. 1998) . Conditions traditionally used to achieve this are eight square wave pulses of 100 ls with a frequency of 1 Hz, using 1.2 kV cm )1 (e.g. 480 V if the electrode gap is 4 mm).
There are some issues that should be considered when performing in vitro electroporation:
1. Cell size. According to eqn 1, cell size is inversely correlated to the size of the external field needed to create permeabilization. Therefore, optimization for each cell type is necessary. From this also follows that the likelihood of a good result increases with homogeneity in cell size and conversely that for cell lines with very large variations in cell size (e.g. Ehrlich ascites cells) it is difficult to obtain good results. Likewise, cell orientation matters for cells that are not spherical. 2. Temperature. It has been shown that membrane resealing is strongly temperature dependent, with slow closure at low temperatures (Kinosita & Tsong 1977b) . For DNA transfer, it has been shown that cooling at the time of permeabilization and subsequent heating in an incubator increases transfer efficacy and cell viability ). 3. Post-pulse manipulation. Cells are vulnerable when in the permeabilized state, and it has been shown that waiting 15 min after electroporation in order to allow resealing before pipetting cells increases cell viability (Gehl et al. 1998) . Cultured cells can as well be permeabilized while growing in, e.g. petri dishes with a simple set of steel plates inserted down into the dish (Zerbib et al. 1985) ; in this way manipulation is avoided. 4. Composition of electrodes and pulsing medium. For short pulses there is probably little need for concern about release of metal from the standard aluminium electrodes used in standard disposable cuvettes. However, when using long pulses this can be a concern. Some authors advocate the use of lowconductivity media for DNA transfer in order to increase viability and increase transfection efficacy . It is generally considered wise to be careful with calcium in the medium during electroporation in order not to cause sudden high intracellular levels of this electrolyte. However, some authors advocate the use of, e.g. calcium or magnesium in the buffer when performing DNA transfer as this will act as a positively charged ÔglueÕ between the negatively charged exterior of the cell and the polyanion DNA, approximating the DNA molecules to the membrane prior to the electroporation procedure (Neumann et al. 1996) .
5. Heating -is not a problem. It has been shown that when using standard electroporation conditions, heating is less than 1°C (Bhatt et al. 1990 ).
Optimizing in vitro electroporation of cells in suspension can be done quite simply by using, e.g. propidium iodide (Sersa et al. 1995 , Gabriel & Teissie 1997 or lucifer yellow , Dinchuk et al. 1992 , and by using, e.g. eight pulses of 100 ls and increasing the voltage until the optimum is found. Such an assay should be accompanied by an investigation of cell death at appropriate voltages.
Some groups have designed particular electroporation systems to cover special needs. Examples of such innovative developments include the use of slides with inbuilt metal strips so that some but not all cells grown on the slide can be electroporated and the function of gap junctions be examined (Raptis et al. 1994) . Also in culture electroporation of single nerve bodies has been described (Teruel & Meyer 1997) .
In vivo electroporation
In vivo electroporation has been performed in a number of different species, either using plate or needle electrodes; an example of such electrodes is shown in Figure 2 . In vivo drug and gene delivery has been carried out in liver (e.g. Heller et al. 1996 , Ramirez et al. 1998 , bladder (Kubota et al. 1996) , brain (Salford et al. 1993 , Nishi et al. 1996 , muscle (e.g. Aihara & Miyazaki 1998 , Mir et al. 1999 and skin (e.g. Prausnitz et al. 1995 , Dujardin et al. 2001 . A recent book reviews various methods (Jaroszeski et al. 2000b) .
Two important features of in vivo electroporation are discussed below.
Electric field distribution
When performing in vitro electroporation in cuvettes, there is a reasonably even electric field (E-field) distribution. Plate electrodes can also been used in the in vivo setting, but often needle electrodes are necessary. When using needle electrodes it is very important to take a look at the field distribution (see, e.g. Miklavcic et al. 1998 . As electroporation is done using fields of, e.g. 1 kV cm
, it is evident that Ôwhole-body electroporationÕ would be a rather dangerous idea. However, as the pulses are very short lasting, several applications can be used to cover a desired area.
Vascular effects
A particular feature of in vivo electroporation is that it causes hypoperfusion in the pulsed areas. We have suggested (Gehl et al. 2002) that this vascular effects is caused by (i) a reflexive constriction of resistance vessels leading to the electroporation area and (ii) a phase of interstitial oedema in interplay with reduced intravascular pressure because of permeabilization of endothelial structures. The reflexive constriction of arterioles last in the order of 1-2 min whereas the interstitial oedema resolves with membrane resealing. Interestingly, this vascular effect seems to be particularly prominent in tumours where the endothelial structures are less mature and the interstitial pressure is higher, and this can, in fact, be turned to an advantage in cancer treatment (Sersa et al. 1999 , Gehl & Geertsen 2000 , Cemazar et al. 2001 .
The consequences of these vascular effects are given below.
The vascular lock. If a drug is present in the tissue before electroporation (e.g. after intratumoral or intramuscular injection), then the vascular effect of the electroporation will mean that just at the time when the cells in the tissue are permeabilized, the drug is retained in the area. We term this the vascular lock (Gehl et al. 2002) .
Optimization of gene transfer. It has been shown that short perfusion delays are linked to reversible permeabilization, and that expression of transferred genes is optimal in this window. Therefore, determining perfusion delays can be a quick method to determine the approximate window of optimal gene transfer (Gehl et al. 2002 ).
An explanation for post-defibrillation cardiac ischaemia? DC-shocks used for defibrillation and cardioversion can cause electroporation of cardiac muscle cells (Tung et al. 1994) . Interestingly, electrocardiogram ST-segment depressions, which are a diagnostic hallmark of cardiac ischaemia, can also be seen after ventricular defibrillation (Tung et al. 1994 , Bardy et al. 1996 . A randomized study on defibrillation equipment compared damped sine wave shocks and truncated biphasic shocks for transthoracic defibrillation (Bardy et al. 1996) . The defibrillation success rate was equal for the two wave forms, but ST-segment depressions 10 s after the shock were significantly more prominent with the damped sine wave shocks, which utilized an applied voltage twice as high as the truncated biphasic shocks. The cause of defibrillation-induced ST-segment depression has not been established previously. From the data presented here, it would be logical to suggest that ST-segment depressions seen after defibrillation are related to vascular reactions to electroporation. Electroporation of cardiac cells may lead to arrhythmias because of transmembrane potential changes and ionic imbalances, an unfortunate event in critically ill cardiac patients. Assuming that there is a link between ST-segment depressions and vascular reactions to electroporation, optimization of defibrillation procedures could be performed by simply looking at the severity and duration of ST-segment depressions.
Relation to electrical injury. Electroporation of muscle and nerve play an important role in electrical injury (Lee & Kolodney 1987) . Electroporation-induced ischaemia may also play a part in this.
Electroporation for DNA transfer
DNA electrotransfer
As previously mentioned, the transfer of DNA to cells is a process where the cell is permeabilized; subsequently DNA will be moved by electrophoretic forces and enter the cell cytosol during the following pulses. As a natural consequence of this, it has been shown that whereas small molecules can diffuse into permeabilized cells in the minutes before membrane resealing, there is no gene transfer if the DNA is added immediately after the pulse (Mir et al. 1999) .
Optimization
Some effort has been put into optimization of conditions for DNA electrotransfer, and the latest develop- Figure 2 An example of plate and needle electrodes, as constructed at our institution. The plate electrodes are constructed of copper plates mounted on non-conductive material. The screw fixes the two plates in parallel position and different gaps can be obtained by combining plates mounted at different widths. The needle electrodes consist of parallel arrays of hypodermic needles inserted into a custom-made platform that ensures good electrical contact as well as stability and parallelism. We have used this type of electrodes both for in vivo work and in the treatment of patients. When performing in vivo electroporation, particular attention should be paid to E-field distributions. E-field calculations for the electrodes shown are presented in Gehl et al. (1999) .
Ó 2003 Scandinavian Physiological Society ment in equipment opens possibilities to design various pulse combinations. There are (at least) three ways to deliver pulses for DNA transfer:
1. Just short, high-amplitude pulses. Using a protocol similar to that used for delivery of small molecules (e.g. six pulses, 100 ls and 1.4 kV cm )1 ), it is possible to obtain a reasonable efficacy and a low mortality (Heller et al. 1996) . 2. Just long, low-amplitude pulses (e.g. eight pulses, 20 ms, 200 kV cm )1 ) (Mir et al. 1999) . The longer pulses have a better electrophoretic effect and therefore transfection rates can be increased. 3. Short, high-amplitude pulse followed by long, lowamplitude pulses (e.g. Bureau et al. 2000) . This pulse combination is based on the concept that after permeabilization with a high amplitude pulse, longduration low-voltage pulses can then drive the DNA across the destabilized membrane.
Electrogenetransfer in vitro
The classic use of electroporation for gene transfer is transfection of bacteria -a topic which is not discussed in the present review. Some important points for in vitro gene transfer to eucaryotic cells were described in the section on ÔOptimization of in vitro electroporation protocolsÕ.
Numerous papers deal with electrogenetransfer to mammalian cells, and a good description of methods can be seen in Jaroszeski et al. (2000b) .
Electrogenetransfer in vivo
Use of electroporation for in vivo electroporation is rapidly attracting interest for several reasons:
1. The use of viral vectors is avoided, reducing safety problems and cost and avoiding the problems caused by antibody formation against the viral vector. 2. Electroporation for gene transfer in vivo has proven highly efficient (see Figs 3 and 4) . In particular, in muscle tissue, where the myofibers neither die nor divide, the electroporation-induced gene transfers that are, in fact, to be considered as transient transfections become functionally permanent with long-term expression (Mir et al. 1999) . Several authors describe up to two log increase in gene expression when comparing direct injection with electrogenetransfer (e.g. Aihara & Miyazaki 1998 , Mir et al. 1999 . 3. The area to which the gene is transferred is clearly delineated by the electrodes. Therefore, gene transfer can be targeted to a certain area, e.g. in the liver.
In vivo electrogenetransfer has been reported in skin (Titomirov et al. 1991 , Heller et al. 2001 , muscle (Aihara & Miyazaki 1998 , Mir et al. 1999 , liver (Heller et al. 1996) , brain (Nishi et al. 1996) and tumours (Rols et al. 1998b ).
Use of electrogenetransfer in the clinical setting
Perspectives for gene therapy Given the above-mentioned advantages of electrotransfer, it is likely that this , and the electroporation parameters: six 99-ms pulses of 1.4 kV cm )1
. The picture was taken 48 h after transfection using a fluorescence microscope equipped with standard FITC filters (by Jens Eriksen, see acknowledgements).
method will soon be put to use also in the clinical setting. Several uses of this technology can be envisaged, e.g. production of ÔmissingÕ proteins in various deficiency syndromes, production of cytokines in the treatment of malignant tumours or production of antigens from tumour cells, enhancing an antitumoural host response.
DNA vaccines. One possible use of in vivo gene transfer by electroporation is for vaccination , Drabick et al. 2001 , Liu & Huang 2002 . It can be anticipated that with small electrodes local gene transfer can be performed giving rise to antigen production either in skin or skeletal muscle. A present problem in vaccination is the need to keep stores of vaccines fresh and to transport them cold, also in warm climates and under difficult conditions. As electroporation equipment can easily be transported and as DNA is very stable, this may facilitate vaccination programmes.
RNA transfection. Electroporation is also increasingly being used for RNA transfer. One particular cell type where RNA transfer has proven to be much more successful than DNA transfer is dendritic cells. Both on murine and human dendritic cells, high transfection efficiencies have been shown (Saeboe-Larssen et al. 2002 , Van Meirvenne et al. 2002 .
Clinical use of electroporation in the treatment of cancer
After the first report of the clinical use of electroporation , several studies have reported the use of electroporation for delivery of chemotherapy (electrochemotherapy) to cancer patients.
It stands to reason, that for lipophilic drugs there is no gain from permeabilizing the cell membrane (Gehl et al. 1998 , Jaroszeski et al. 2000a . The two drugs that have been used in the clinical setting are bleomycin and cisplatinum. Bleomycin is a hydrophilic and charged molecule, which under normal circumstances, is only internalized in limited amounts (Mir et al. 1996) . It is, however, a very cytotoxic drug. Acting as an enzyme each bleomycin molecule creates several DNA double strand breaks (Tounekti et al. 1993) . With the use of electroporation to introduce bleomycin directly into the cell cytosol, its cytotoxicity can be increased 300-5000-fold (Orlowski et al. 1988 , Gehl et al. 1998 , Jaroszeski et al. 2000a ). In the case of cisplatinum, the increase in cytotoxicity is limited to 2-13-fold (Sersa et al. 1995 , Gehl et al. 1998 , Jaroszeski et al. 2000a , which is, however, still a considerable gain.
Several different cancer types have been treated: basal cell carcinoma (Glass et al. 1997) , malignant melanoma (Heller et al. 1998 , Gehl & Geertsen, 2000 , Sersa et al. 2000b , adenocarcinoma , squamous cell carcinoma , Panje et al. 1998 , transitocellular carcinoma (Kubota et al. 1998) and renal cell carcinoma (Sersa et al. 2000c) .
In all of these histologically different cancer types, electrochemotherapy was highly efficient. As an example, in one study of skin tumours of various histologies, the complete disappearance of tumours using once-only electrochemotherapy was 90% (Heller et al. 1998) .
What matters in electrochemotherapy is actually the anatomy that restricts the placement of the electrodes and thus the E-field, rather than chemosensitivity of the tumours, which are subject to overkill given the hundreds-of-folds increase in cytotoxicity induced.
Side-effects to electrochemotherapy are modest. With adequate local anaesthesia, brief contractions of the underlying musculature are the main side-effect. Although up till now principally skin tumours have been treated, it is anticipated that electrode systems for deeper situated tumours will be developed. As electrochemotherapy can be performed very quickly and as a once-only treatment, it would also be possible to do electrochemotherapy during open surgery.
Immunological effects of electroporation
Several studies have shown that there is an immunogenic effect of electroporation. The weak immunogenic effect of electroporation alone can be strengthened by the addition of bleomycin and there is a synergistic effect when combined with interleukin-2 or other cytokines. The nature of this immunogenic effect is not established, but release of antigens from the cytosol or changes in the cell membrane are possible candidates. Animal studies have shown that the combination of electrochemotherapy and interleukin-2 in a synergistic way:
1. enhances the local anti-tumour effect in the treated area (Mir et al. 1995) ; 2. also affects tumours implanted in other sites of the same animal (Mir et al. 1995) ; 3. can reduce the frequency of metastases, leading to longer survival , Ramirez et al. 1998 ); 4. can induce a memory effect, so that treated animals did not develop tumours of a given type when re-challenged at a later time (Mir et al. 1995) ; 5. finally, it has been shown that blocking of the immune system can block the systemic effect of electrochemotherapy (Mir et al. 1992) .
One of the human cancers known to respond to immunotherapy is malignant melanoma. We have, therefore, initiated a Phase II clinical study where patients with advanced malignant melanoma are treated Ó 2003 Scandinavian Physiological Society with electrochemotherapy of cutaneous metastases followed by local, subcutaneous injections of interleukin-2. Preliminary results (Gehl et al. 2001) show that this treatment has clinical efficacy with modest sideeffects. Paraclinical studies of the immunoreactivity of circulating lymphocytes show that responses against known melanoma antigens are induced (Andersen et al., manuscript submitted). These results point out that electrochemotherapy may be used not only as a treatment for localized tumours, but also in combination with interleukin-2 and/or other cytokines, and also in the treatment of systemic disease.
Drug delivery through skin by electroporation
Beyond the scope of this review, but not to be left unmentioned, is that a considerable amount of literature describes the use of local electric pulses to deliver drugs through the skin, and this is likely to hold future for parenteral controlled delivery of a number of otherwise non-permeating molecules. For reviews, see Prausnitz (1999) , Vanbever & Preat (1999) , Weaver et al. (1999) and Jaroszeski et al. (2000b) .
Perspectives
The perspective of electroporation is that a wide range of molecules, e.g. ions, drugs, dyes, DNA, proteins, oligonucleotides, can be introduced directly into the cell cytosol in vitro, in vivo and in patients. The electroporation technology has been in development over the past decades, both regarding equipment and sophistication of electroporation protocols based on increased knowledge of the processes involved in electroporation. Clearly, this opens many perspectives both for researchers and physicians in various fields.
Jens Eriksen, PhD, Department of Oncology, Herlev Hospital, performed experiments shown in Figure 3 .
